KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Non-Current Deffered Revenue (2016 - 2018)

CareDx's Non-Current Deffered Revenue history spans 6 years, with the latest figure at $470000.0 for Q4 2018.

  • On a quarterly basis, Non-Current Deffered Revenue fell 48.52% to $470000.0 in Q4 2018 year-over-year; TTM through Dec 2018 was $470000.0, a 48.52% decrease, with the full-year FY2018 number at $470000.0, down 48.52% from a year prior.
  • Non-Current Deffered Revenue hit $470000.0 in Q4 2018 for CareDx, down from $579000.0 in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for CDNA hit a ceiling of $1.8 million in Q2 2014 and a floor of $470000.0 in Q4 2018.
  • Historically, Non-Current Deffered Revenue has averaged $1.0 million across 5 years, with a median of $857500.0 in 2017.
  • Biggest five-year swings in Non-Current Deffered Revenue: crashed 57.2% in 2016 and later rose 20.29% in 2017.
  • Tracing CDNA's Non-Current Deffered Revenue over 5 years: stood at $1.7 million in 2014, then dropped by 15.32% to $1.4 million in 2015, then crashed by 46.77% to $759000.0 in 2016, then rose by 20.29% to $913000.0 in 2017, then tumbled by 48.52% to $470000.0 in 2018.
  • Business Quant data shows Non-Current Deffered Revenue for CDNA at $470000.0 in Q4 2018, $579000.0 in Q3 2018, and $711000.0 in Q2 2018.